Alveolar soft part sarcoma (ASPS) is a rare type of cancer that affects soft tissues such as muscles, tendons, and ligaments. It usually occurs in the lower extremities, but can also occur in other parts of the body. ASPS is a slow-growing cancer that can spread to other parts of the body, including the lungs, liver, and brain. Treatment typically involves surgery, radiation, and chemotherapy.

The most common symptoms of Alveolar Soft Part SarComa (ASPS) include:

-A lump or mass in the soft tissue of the body, usually in the lower extremities
-Pain or tenderness in the area of the lump
-Swelling in the area of the lump
-Fever
-Weight loss
-Fatigue
-Night sweats
-Loss of appetite
-Nausea
-Vomiting
-Abdominal pain
-Joint pain
-Limping
-Difficulty breathing
-Coughing up blood

The exact cause of Alveolar Soft Part Sarcoma (ASPS) is unknown. However, research suggests that it may be caused by a combination of genetic and environmental factors. Some studies have suggested that certain genetic mutations may be linked to the development of ASPS, while others have suggested that exposure to certain environmental toxins may increase the risk of developing the disease.

The main treatment for Alveolar Soft Part Sarcoma (ASPS) is surgery. Depending on the size and location of the tumor, a combination of surgery, radiation therapy, and chemotherapy may be used. Surgery is the primary treatment for ASPS and may involve removing the tumor and some surrounding tissue. Radiation therapy may be used to reduce the size of the tumor before surgery or to reduce the risk of recurrence after surgery. Chemotherapy may be used to shrink the tumor before surgery or to reduce the risk of recurrence after surgery.

1. Exposure to radiation
2. Genetic predisposition
3. Exposure to certain chemicals
4. Family history of the disease
5. Being female
6. Being of Asian descent

At this time, there is no known cure for Alveolar Soft Part Sarcoma. Treatment typically involves a combination of chemotherapy, radiation therapy, and surgery. Medications used to treat Alveolar Soft Part Sarcoma include doxorubicin, ifosfamide, and vincristine.